Genetic interactions between Ror2 and Wnt9a, Ror1 and Wnt9a and Ror2 and Ror1: Phenotypic analysis of the limb skeleton and palate in compound mutants

被引:14
|
作者
Weissenboeck, Martina [1 ]
Latham, Richard [1 ]
Nishita, Michiru [2 ]
Wolff, Lena Ingeborg [3 ]
Ho, Hsin-Yi Henry [4 ]
Minami, Yasuhiro [2 ]
Hartmann, Christine [3 ]
机构
[1] Res Inst Mol Pathol, Vienna, Austria
[2] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cell Physiol, Kobe, Hyogo, Japan
[3] Univ Munster, Inst Musculoskeletal Med, Med Fac, Dept Bone & Skeletal Res, Munster, Germany
[4] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA
基金
美国国家卫生研究院;
关键词
chondrogenesis; endochondral ossification; limb skeleton; Ror1; Ror2; secondary cleft palate; Wnt9a; RECEPTOR TYROSINE KINASE; NONSYNDROMIC CLEFT-LIP; RECESSIVE ROBINOW-SYNDROME; PATHWAY; MOUSE; MUTATION; WNT5A; EXPRESSION; FAMILY; MICE;
D O I
10.1111/gtc.12676
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mutations in the human receptor tyrosine kinase ROR2 are associated with Robinow syndrome (RRS) and brachydactyly type B1. Amongst others, the shortened limb phenotype associated with RRS is recapitulated in Ror2(-/-) mutant mice. In contrast, Ror1(-/-) mutant mice are viable and show no limb phenotype. Ror1(-/-);Ror2(-/-) double mutants are embryonic lethal, whereas double mutants containing a hypomorphic Ror1 allele (Ror1(hyp)) survive up to birth and display a more severe shortened limb phenotype. Both orphan receptors have been shown to act as possible Wnt coreceptors and to mediate the Wnt5a signal. Here, we analyzed genetic interactions between the Wnt ligand, Wnt9a, and Ror2 or Ror1, as Wnt9a has also been implicated in skeletal development. Wnt9a(-/-) single mutants display a mild shortening of the long bones, whereas these are severely shortened in Ror2(-/-) mutants. Ror2(-/-);Wnt9a(-/-) double mutants displayed even more severely shortened long bones, and intermediate phenotypes were observed in compound Ror2;Wnt9a mutants. Long bones were also shorter in Ror1(hyp/hyp);Wnt9a(-/-) double mutants. In addition, Ror1(hyp/hyp);Wnt9a(-/-) double mutants displayed a secondary palate cleft phenotype, which was not present in the respective single mutants. Interestingly, 50% of compound mutant pups heterozygous for Ror2 and homozygous mutant for Ror1 also developed a secondary palate cleft phenotype.
引用
收藏
页码:307 / 317
页数:11
相关论文
共 50 条
  • [1] ROR1 and ROR2 expression in pancreatic cancer
    Dongli Liu
    George Sharbeen
    Phoebe Phillips
    Caroline E. Ford
    [J]. BMC Cancer, 21
  • [2] ROR1 and ROR2 expression in pancreatic cancer
    Liu, Dongli
    Sharbeen, George
    Phillips, Phoebe
    Ford, Caroline E.
    [J]. BMC CANCER, 2021, 21 (01)
  • [3] Comparative genomics on ROR1 and ROR2 orthologs
    Katoh, M
    Katoh, M
    [J]. ONCOLOGY REPORTS, 2005, 14 (05) : 1381 - 1384
  • [4] Cellular and Biochemical Activities of the Non-Canonical Wnt Receptors ROR1 and ROR2
    Bainbridge, T. W.
    De Almeida, V.
    Chalouni, C.
    Kelly, R.
    Goldsmith, J.
    Majeed, A.
    Pan, B.
    Quinones, G.
    Lill, J.
    Sandoval, W.
    Izrael-Tomasevic, A.
    Arnott, D.
    Costa, M.
    Polakis, P.
    Rubinfeld, B.
    Ernst, J. A.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [5] Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
    Yu, Jian
    Chen, Liguang
    Cui, Bing
    Widhopf, George F., II
    Shen, Zhouxin
    Wu, Rongrong
    Zhang, Ling
    Zhang, Suping
    Briggs, Steven P.
    Kipps, Thomas J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (02): : 585 - 598
  • [6] Identification and characterization of rat Ror1 and Ror2 genes in silico
    Katoh, M
    Katoh, M
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 15 (03) : 533 - 538
  • [7] ROR1 and ROR2 in human malignancies: potentials for targeted therapy
    Rebagay, Guilly
    Yan, Su
    Liu, Cheng
    Cheung, Nai-Kong
    [J]. FRONTIERS IN ONCOLOGY, 2012, 2
  • [8] ROR1 and ROR2 play distinct and opposing roles in endometrial cancer
    Henry, C. E.
    Llamosas, E.
    Daniels, B.
    Coopes, A.
    Tang, K.
    Ford, C. E.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 148 (03) : 576 - 584
  • [9] Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies
    Daneshmanesh, Amir Hossein
    Porwit, Anna
    Hojjat-Farsangi, Mohammad
    Jeddi-Tehrani, Mahmood
    Tamm, Katja Pokrovskaja
    Grander, Dan
    Lehmann, Soren
    Norin, Stefan
    Shokri, Fazel
    Rabbani, Hodjattallah
    Mellstedt, Hakan
    Osterborg, Anders
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 843 - 850
  • [10] Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells
    Wu, Xuping
    Yan, Ting
    Hao, Leiyu
    Zhu, Yichao
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2803 - 2815